inactivated ev-a71
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Apr 30, 2019 (NCT03893747)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Human enterovirus 71Immunity, active
Human enterovirus 71 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03893747 | Phase 4 | Apr 30, 2019 | Government of China, Wuhan Institute of Biological Products Co., Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 1 | 1 | 1 | 2019 |
| Wuhan Institute of Biological Products Co., Ltd | Government | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1